Current and Novel Inhibitors of HIV Protease

By Pokorná Jana   Machala Ladislav   Řezáčová Pavlína   Konvalinka Jan  

Viruses, Vol. 1, Iss. 3, 2009-12 ,pp. : 1209-1239

MDPI

Access to resources Recommend Favorite

HIV-1 Entry, Inhibitors, and Resistance

By Lobritz Michael A.   Ratcliff Annette N.   Arts Eric J.  

Viruses, Vol. 2, Iss. 5, 2010-04 ,pp. : 1069-1105

MDPI

Access to resources Recommend Favorite

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors

By Latronico Tiziana   Mascia Claudia   Pati Ilaria   Zuccala Paola   Mengoni Fabio   Marocco Raffaella   Tieghi Tiziana   Belvisi Valeria   Lichtner Miriam   Vullo Vincenzo   Mastroianni Claudio Maria   Liuzzi Grazia Maria  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-03 ,pp. : 455-455

MDPI

Access to resources Recommend Favorite

Computational Studies of a Mechanism for Binding and Drug Resistance in the Wild Type and Four Mutations of HIV-1 Protease with a GRL-0519 Inhibitor

By Hu Guodong   Ma Aijing   Dou Xianghua   Zhao Liling   Wang Jihua  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-05 ,pp. : 819-819

MDPI

Access to resources Recommend Favorite

Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors

By Singh Kamalendra   Flores Jacqueline A.   Kirby Karen A.   Neogi Ujjwal   Sonnerborg Anders   Hachiya Atsuko   Das Kalyan   Arnold Eddy   McArthur Carole   Parniak Michael   Sarafianos Stefan G.  

Viruses, Vol. 6, Iss. 9, 2014-09 ,pp. : 3535-3562

MDPI

Access to resources Recommend Favorite